# FDA Inspection 1009225 - Vitalant - April 18, 2017

Source: https://www.keypedia.com/records/fda_inspections/vitalant/28a89513-b90a-4ba4-a459-011efca7d337
Source feed: FDA_Inspections

> FDA Inspection 1009225 for Vitalant on April 18, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1009225
- Company Name: Vitalant
- Inspection Date: 2017-04-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1278748 - 2025-07-22](https://www.keypedia.com/records/fda_inspections/vitalant/aa72afe7-7b6c-4543-8f4e-8aa375f13b2d)
- [FDA Inspection 1278748 - 2025-07-22](https://www.keypedia.com/records/fda_inspections/vitalant/c8f242bc-99e0-41e4-9b5c-5cf25be85d25)
- [FDA Inspection 1211673 - 2023-08-02](https://www.keypedia.com/records/fda_inspections/vitalant/0fe08d28-805d-40b6-b77d-acf52f747cc0)
- [FDA Inspection 1101239 - 2019-07-16](https://www.keypedia.com/records/fda_inspections/vitalant/6165333a-a0df-401d-b7f7-782c22281273)
- [FDA Inspection 899398 - 2014-10-08](https://www.keypedia.com/records/fda_inspections/vitalant/580b51f6-9aed-464c-87e2-67d6638f3667)

Company: https://www.keypedia.com/companies/vitalant/cc782b46-8d7e-44d6-b03e-42f305c87c06

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d